Jazz Pharmaceuticals (JAZZ) jumped 4.89% over the past two days after announcing better-than-expected earnings. Quarterly revenues increased 67.7% year over year to $208.3 million. Second-quarter 2013 adjusted earnings of $1 per share were well above the year-ago earnings of 81 cents per share.
With your September 2013 $70.000 calls (JAZZ130921C00070000) now up 101.64%, sell all of your remaining options to lock in these triple-digit percentage gains.
With Jazz Pharmaceuticals (JAZZ) up 40.99% since my initial recommendation on May 13, raise your stop in the stock to $78.30 to lock in at least a 35% gain in the stock.
let's see which category it takes... It takes Stock Investor that is the new Uncategorized
This content is for paid subscribers only. To gain access subscribe to one of our…
It is hard to find a seasoned investor who doesn’t believe the stock market is…
No one believes a financial disaster can strike… until it’s too late. That’s bizarre, considering…
The Options Industry Council is a resource used to educate investors about the benefits and…